OMEROS CORP Annual Operating Income (Loss) in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Omeros Corp quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
  • Omeros Corp Operating Income (Loss) for the quarter ending June 30, 2024 was -$59.2M, a 44.6% decline year-over-year.
  • Omeros Corp Operating Income (Loss) for the twelve months ending June 30, 2024 was -$186M, a 11.1% decline year-over-year.
  • Omeros Corp annual Operating Income (Loss) for 2023 was -$165M, a 0.7% decline from 2022.
  • Omeros Corp annual Operating Income (Loss) for 2022 was -$163M, a 5.89% increase from 2021.
  • Omeros Corp annual Operating Income (Loss) for 2021 was -$174M, a 10.6% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$165M -$1.14M -0.7% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-01
2022 -$163M +$10.2M +5.89% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-01
2021 -$174M -$16.7M -10.6% Jan 1, 2021 Dec 31, 2021 10-K 2024-04-01
2020 -$157M -$10.9M -7.45% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-13
2019 -$146M -$33.8M -30.1% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 -$112M -$68.3M -156% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-01
2017 -$43.9M +$10.4M +19.1% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-02
2016 -$54.3M +$17M +23.8% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-01
2015 -$71.2M -$1.23M -1.76% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-01
2014 -$70M -$19.5M -38.6% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-16
2013 -$50.5M -$13.6M -37% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-15
2012 -$36.9M -$9.48M -34.6% Jan 1, 2012 Dec 31, 2012 10-K 2015-03-16
2011 -$27.4M +$2.7M +8.96% Jan 1, 2011 Dec 31, 2011 10-K 2014-03-13
2010 -$30.1M Jan 1, 2010 Dec 31, 2010 10-K 2013-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.